Study reveals bias in immunotherapy machine learning tools, impacting custom treatments. Addressing dataset bias crucial for inclusive and effective therapies.
A new machine learning model predicts the benefit of oxaliplatin in stage 3 colon cancer patients. Discover how the COLOXIS model identifies which patients will benefit from oxaliplatin in treatment regimens, reducing unnecessary adverse events and improving personalized care. Further research is needed to validate and optimize the model for clinical practice.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?